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The most frequent reason for revision in the 1st year after total 
hip arthroplasty (THA) is dislocation (LROI annual report 
2016). Dislocation of a hip prosthesis is multifactorial includ-
ing femoral head diameter. Mechanical studies have shown 
that instability could be decreased by increasing the diameter 
of the femoral head. With a larger head diameter, the head–
neck ratio is higher and therefore there is a lower potential for 
instability (Burroughs et al. 2005).
Dual articulation implants were designed to increase 
implant stability but also to decrease polyethylene rim damage 
from contact between femoral neck and acetabular liner and 
to restore near-normal range of motion. The dual mobility cup 
(DMC) is a ‘cup in a cup’ and was developed in the 1970s 
to combine the low-friction arthroplasty principle of Charnley 
with the advantage of a big femoral head principle of McKee 
(Philippot et al. 2009). 
Despite concerns about increased polyethylene wear due to 
the large femoral head, the DMC is not only used for revisions 
but also in primary THA to reduce dislocations. This was 
shown by De Martino et al. (2017) who counted, in a review 
of English articles between 1974 and 2016, 12,844 primary 
DMC THA and 5,064 revision DMC THA. Many of these 
articles focused more on dislocation rates than on longevity of 
the implant. Also in our daily practice we noticed an increase 
in the use of DMC in primary THA. Therefore, we determined 
the trend over time and mid-term cup revision rates of DMC 
compared with unipolar cup (UC) in primary THA with data 
from the Dutch Arthroplasty Register. 
Patients and methods
The Dutch Arthroplasty Register (LROI) is a nationwide pop-
ulation-based register that includes information on arthroplas-
ties in the Netherlands since 2007. The LROI was initiated 
by the Netherlands Orthopaedic Association and is well sup-
Background and purpose — We noticed an increased 
use of dual mobility cups (DMC) in primary total hip arthro-
plasty (THA) despite limited knowledge of implant longev-
ity. Therefore, we determined the trend over time and mid-
term cup revision rates of DMC compared with unipolar 
cups (UC) in primary THA.
Patients and methods — All primary THA registered in 
the Dutch Arthroplasty Register (LROI) during 2007–2016 
were included (n = 215,953) and divided into 2 groups — 
DMC THA (n = 3,038) and UC THA (n = 212,915). Crude 
competing risk and multivariable Cox regression analyses 
were performed with cup revision for any reason as primary 
endpoint. Adjustments were made for sex, age, diagnosis at 
primary THA, previous operation, ASA score, type of fixa-
tion, surgical approach, and femoral head size.
Results — The proportion of primary DMC THA 
increased from 0.8% (n = 184) in 2010 to 2.6% (n = 740) in 
2016. Patients who underwent DMC THA more often had a 
previous operation on the affected hip, a higher ASA score, 
and the diagnosis acute fracture or late posttraumatic status 
compared with the UC THA group. Overall 5-year cup revi-
sion rate was 1.5% (95% CI 1.0–2.3) for DMC and 1.4% (CI 
1.3–1.4) for UC THA. Stratified analyses for patient charac-
teristics showed no differences in cup revision rates between 
the 2 groups. Multivariable regression analyses showed no 
statistically significantly increased risk for revision for DMC 
THA (HR 0.9 [0.6–1.2]).
Interpretation — The use of primary DMC THA 
increased with differences in patient characteristics. The 
5-year cup revision rates for DMC THA and UC THA were 
comparable.
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The LROI database contains information on patient, pro-
cedure, and prosthesis characteristics registered by registrars 
from each hospital. For each component a product number 
is registered to identify the characteristics of the prosthesis. 
The vital status of all patients is obtained actively on a regular 
basis from Vektis, the national insurance database on health 
care in the Netherlands, which records all deaths of Dutch citi-
zens. The LROI uses the opt-out system to require informed 
consent of patients.
For the present study we included all patients that under-
went a primary THA in the period 2007–2016. Metal-on-metal 
(MoM) THA (n = 6,626) and records with a missing product 
number (n  = 7,017) were excluded. The remaining 215,953 
hips comprised 3,038 DMC THAs and 212,915 UC THAs. 
Diagnosis was categorized as osteoarthritis (OA), acute frac-
ture, late posttraumatic, and other. Other diagnoses registered 
in the LROI are dysplasia, inflammatory arthritis, osteonecro-
sis, post-Perthes, and tumor (unspecified). Cup revision was 
defined as a revision procedure where at least the cup was 
exchanged or removed. Closed reduction after a dislocation 
or incision and drainage for infection were not included in the 
LROI. The median follow-up was 3 years (0–9). 
Statistics
Survival time was calculated as the time from primary THA to 
1st revision arthroplasty for any reason, death of the patient, or 
the end of the study follow-up (January 1, 2017). Cumulative 
crude incidence of revision was calculated using competing 
risk analysis, where death was considered to be a competing 
risk (Lacny et al. 2015, Wongworawat et al. 2015). In addition 
Kaplan–Meier survival analyses were performed. 
Multivariable Cox proportional hazard ratios were per-
formed to compare adjusted revision rates between DMC and 
UC THA. Adjustments were made for sex, age at surgery, 
diagnosis at primary THA, previous operation, ASA score, 
type of fixation, surgical approach, and diameter of the femo-
ral head to discriminate independent risk factors for cup revi-
sion arthroplasty. BMI, Charnley score, and smoking status 
were not included as covariates, since these were only avail-
able in the LROI database since 2014. For all covariates added 
to the model, the proportional hazards assumption was met 
after inspecting log-minus-log curves. 
Reasons for revision were described according to type of 
hip arthroplasty and compared using a chi-square test to test 
differences between types of THA (SPSS 22.0; IBM Corp, 
Armonk, NY, USA). 
More than 1 reason could be chosen. P-values below 0.05 
were considered statistically significant. For the 95% confi-
dence intervals (CI), we assumed that the number of observed 
cases followed a Poisson distribution. 
Ethics, funding, and potential conflicts of interests 
The dataset was processed in compliance with the regulations 
of the LROI governing research on registry data. No external 
funding was received. No competing interests were declared. 
Results
The use of DMC THA increased from 184 (0.8% of all THAs) 
in 2010 to 740 (2.6% of all THAs) in 2016 (Figure 1) with 8 
different types of DMC used (Table 1). 
In the DMC THA group more patients had undergone previ-
ous surgery on the affected hip and had a higher ASA score. 
Furthermore the distribution of diagnoses at primary surgery 
was different compared with the UC THA group (Table 2). 
The 5-year crude cup revision rate for DMC THA was 1.5% 
(CI 1.0–2.3) and 1.4% (CI 1.3–1.4) for UC THA (Figure 2). 
Stratified analyses according to diagnosis at primary THA, 
previous surgery on the affected hip, and fixation of the cup 
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Figure 1. Trend in the use of dual mobil-
ity cup (DMC) in total hip arthroplasty 
(THA) in the period 2010–2016 in the 
Netherlands (n = 3,038).
Table 1. Types of dual mobility cup THA used in the 
period 2007–2016 the Netherlands (n = 3,038)
Type  Cemented Cementless
Biomet Avantage 1,904 84
Biomet Avantage Reload –  339
Biomet Avantage Rev HA – 5
Smith & Nephew Polarcup 79 273
Amplitude Saturne 164 85
Mathys SeleXys DS Cup  27 54
Groupe Lepine Cupule Quattro 17 –
Groupe Lepine Cupule HAP Press-F – 7
Figure 2. Cumulative incidence of cup 
revision according to type of cup (all 
diagnoses) in the period 2007–2016 in 
the Netherlands (n = 215,953). THA: 
total hip arthroplasty. 
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ported by its members. This results in coverage of 
100% of Dutch hospitals and a completeness of 
reporting of over 95% for primary THAs and 88% 
for hip revision arthroplasty (Van Steenbergen et 
al. 2015). 
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showed similar 5-year crude cumulative incidence of cup revi-
sions between the DMC and UC THA groups (Table 3 and 4, 
see Supplementary data). 
The unadjusted hazard ratio for cup revision of DMC THA 
compared with UC THA was 1.2 (CI 0.8–1.6). Moreover, 
multivariable survival analyses showed a comparable risk for 
cup revision for DMC THA (HR 0.8 [CI 0.6–1.2]). 
Dislocation was the most frequently registered reason for 
revision in UC THA patients (0.5%), while in the DMC THA 
group 0.2% were revised due to dislocation. In the DMC THA 
group loosening of the cup, dislocation, and infection were 
mostly registered as reason for revision (Table 5, see Sup-
plementary data). From the 18 DMCs that loosened 8 were 
cemented. 
Discussion
We showed that the use of primary DMC THA increased in 
the Netherlands, with differences in patient characteristics 
between DMC and UC THA patients. The 5-year revision 
rates were comparable, with no differences in specific sub-
groups. 
Our study is the first register study focusing on cup sur-
vival in primary use of DMC. Our 5-year cumulative inci-
dences of cup revision of 1.5% in DMC THA and 1.4% in 
UC THA are lower than the overall revision rates from the 
Australian Orthopaedic Association National Joint Replace-
ment Registry (2016), which reported 4.6% revision in 2,640 
primary DMC THA and 3.3% in 327,847 primary UC THA. 
They did not specify the type of revision (insert, femoral 
head, cup, stem, or all). They also performed subgroup anal-
ysis and did not find a higher revision rate in any subgroup 
(AOANJRR 2016). 
Our results differ from the Swedish Hip Arthroplasty Regis-
ter (2016) where a hazard ratio of 2.4 for revision of Avantage 
DMC THA compared with UC THA after correction for case 
mix factors and after exclusion of infections was found. How-
ever, their result is also based on the overall revision rates, 
while our HR of 0.8 is based on cup revisions only.
Risk for cup revision due to dislocations was low with pri-
mary use of a DMC. In our study 8/3,038 (0.2%) DMC THA 
patients had a cup revision because of a dislocation versus 
1,017/215,953 (0.5%) in UC THA. Tarasevicius et al. (2017) 
found in the Lithuanian Arthroplasty register at 5 years a revi-
sion rate for dislocation of 4/620 (0.7%) for primary DMC 
THA in comparison with 52/2,170 (2.4%) in a cemented 
Exeter cup. Revisions of UC THA are often preceded by 1 or 
more closed reductions (which are not reported in arthroplasty 
registers), while dislocations of DMC THA, being intra-pros-
thetic or not, are difficult to treat by closed reduction and will 
more often need surgery with exchange of components (which 
are reported in arthroplasty registers). So revision rates for 
dislocation in UC and DMC do not reflect instability in the 
same way.
(Suspicion of) infection was the second commonest reason 
for cup revision in the DMC THA group (10/36). In the LROI 
only (suspected) prosthetic joint infections as reason for revi-
sion were registered. As shown earlier, implant registries 
largely underscore prosthetic joint infections (Gundtoft et 
al. 2015) since incisions and drainages without component 
exchange are not included. In this respect Mukka et al. (2013) 
published a study of 34 hips with DMC THA with soft-tissue 
debridement of 3 hips due to superficial infection. Chughtai et 
al. (2016) reported 453 primary DMC THA with 2 septic revi-
sions after 2 years. Differences in patient characteristics and 
particularly comorbidities are probably the explanation for 
our high amount (0.3%) of revisions due to suspected infec-
tion (Radtke et al. 2016). Furthermore, differences in hospi-
tal guidelines (early debridement in the case of wound prob-
lems), diagnosis, and treatment of implant infections could be 
a reason for more reported infections (Osmon et al. 2013).
Comparable risk for revision rates was seen between 
cemented and uncemented cups. Batailler et al. (2017) 
Table 2. Patient characteristics in THA according to type of acetab-
ular cup (n  = 212,915). Values are frequency and (%) unless other-
wise specified
 DMC THA UC THA
 n  = 3,038 n = 212,915
Male sex, n (%) 1,104 (36) 70,144 (33)
Mean age (SD)  70 (13) 69 (11)
Operations before (yes) 632 (21) 10,048 (5)
ASA
 I 308 (10) 47,409 (22)
 II 1,724 (57) 129,460 (61)
 III–IV 951 (31) 27,748 (13)
Fixation
 Cemented 1,710 (56) 60,955 (29)
 Hybrid (acetabulum cemented) 495 (16) 9,033 (4)
 Hybrid (femur cemented) 126 (4) 9,932 (5)
 Uncemented 674 (22) 130,911 (62)
Diagnosis
 Osteoarthritis 1,688 (56) 185,062 (87)
 Fracture (acute) 424 (14) 7,065 (3)
 Late posttraumatic 406 (13) 4,415 (2)
 Other a 476 (16) 14,163 (7)
Approach
 Anterior 96 (3) 21,102 (10)
 Anterolateral 41 (1) 15,801 (7)
 Direct lateral 254 (8) 44,249 (21)
 Posterolateral 2,607 (86) 128,275 (60)
 Trochanter osteotomy 1 (0) 71 (0)
 Other 8 (0) 635 (0)
Diameter (mm)
 22–28 2,784 (92) 66,703 (31)
 32 – 93,619 (44)
 36 – 4,002 (19)
 ≥ 38 – 1,452 (1)
Numbers do not add up to total due to missing data.
DMC: dual mobility cup; UC: unipolar cup; THA: total hip arthroplasty.
a Other: dysplasia, inflammatory arthritis, osteonecrosis, post-
  Perthes, tumor (unspecified).
14 Acta Orthopaedica 2019; 90 (1): 11–14
reviewed 21 studies with different cementless DMCs in pri-
mary THA with 0–8% aseptic loosenings after 2–22 years. 
They argued that the fixation of cementless DMC can be 
affected by poor bone quality. This could have been the case 
in patients with (post)traumatic diagnosis or other comor-
bidities. 
Strengths of our study are, first, that the LROI contains a 
large population-based nationwide database of primary THAs, 
with a completeness of nearly 100% (van Steenbergen et 
al. 2015, LROI 2016) and an 8-year follow-up. Second, we 
focused our analyses on cup revisions, since type of revision 
(cup, stem, insert, and/or femoral head exchange) is specified 
in the LROI. 
A limitation of this study is that in registries only limited 
variables are collected, correctness of data cannot be proven, 
and causality cannot be proven due to its observational nature. 
This might lead to residual confounding. Furthermore, closed 
dislocations are missed, since this procedure is not regis-
tered in the LROI, when no prosthesis component is added, 
exchanged, or removed. Dislocations for a DMC THA are 
almost always registered in the LROI since closed dislocation 
for DMC THA is most often impossible. Conversely, closed 
dislocation for UC THA can often be performed without sur-
gery. This could lead to a lower revision rate in the UC THA 
group. The limited reliability of a diagnosis of infection has 
been discussed above.
In summary, the use of primary DMC THA in the Nether-
lands increased with differences in patient characteristics in 
comparison with UC THA. The 5-year revision rates for DMC 
THA were comparable to UC THA, even after adjustment for 
casemix factors. However, we need to be aware of residual 
confounding. To determine the exact role of DMC in primary 
THA compared with UC, randomized controlled trials or more 
subgroup analyses are needed. 
Supplementary data
Tables 3–5 are available as supplementary data in the online 
version of this article, http://dx.doi.org/ 10.1080/17453674. 
2018.1542210
All authors contributed to the conception of the study, data analysis, and 
preparation of the manuscript.
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Table 4. Kaplan–Meier revision rates (%) according to type of cup
 DMC THA UC THA
  5-year  5-year
  cumulative  cumulative
  revision  revision 
 n  rate (CI) n  rate (CI)
Overall 3,038 1.7 (1.0–2.5) 212,915 1.4 (1.4–1.4) 
Diagnosis
 Osteoarthritis 1,688 1.7 (0.7–2.8) 185,062 1.3 (1.3–1.3)
 Non-osteoarthritis 1,306  1.6 (0.8–2.4) 25,643 2.1 (1.9–3.0)
Previous surgery
 No 2,406 1.8 (0.9–2.9) 202,867 1.4 (1.4–1.4)
 Yes 632 1.5 (0.1–1.6) 10,048 2.3 (2.0–2.7)
Cemented
 Yes 2,205 1.8 (0.6–3.0) 69,988 1.7 (1.5–2.7)
 No 800 1.7 (0.7–2.7) 140,843 1.3 (1.3–1.3) 
Numbers do not add up to total due to missing data.
For abbreviations, see Table 2.
Table 3. Crude 5-year cumulative incidence (%) of cup revision 
according to type of cup
 DMC THA UC THA
  5-year  5-year 
  cumulative  cumulative
  incidence of  incidence of
 n  revision (CI) n revision (CI)
Overall (all records) 3,038 1.5 (1.0–2.3) 212,915 1.4 (1.3–1.4)
Diagnosis
 Osteoarthritis 1,688 1.6 (0.9–2.9) 185,062 1.3 (1.2–1.4)
 Non-osteoarthritis 1,306 1.4 (0.8–2.4) 25,643 2.0 (1.9–2.2)
Previous surgery
 No 2,406 1.7 (1.1–2.7) 202,867 1.3 (1.3–1.4)
 Yes 632 1.3 (0.5–3.2) 10,048 2.2 (1.9–2.5)
Cemented cup
 Yes 2,197 1.5 (0.9–2.6) 69,988 1.6 (1.5–1.7)
 No 795 1.6 (0.8–3.1) 140,843 1.3 (1.2–1.3)
Numbers do not add up to total due to missing data
For abbreviations, see Table 2.
Table 5. Reason for cup revision according to type of cup. Values 
are frequency and (%)
 DMC THA UC THA
Reason for revision n  = 3,038 n = 212,915
Dislocation 8 (0.2) 1,017 (0.5)
Infection 10 (0.3) 451 (0.2)
Periprosthetic fracture 3 (0.0) 98 (0.0)
Cup/liner wear 1 (0.0) 85 (0.0)
Girdlestone/spacer a 3 (0.0) 173 (0.1)
Loosening acetabular component 18 (0.5) 648 (0.3)
Loosening femoral component 2 (0.0) 227 (0.1)
Peri-articular ossification 1 (0.0) 40 (0.0)
Other 4 (0.3) 435 (0.2)
More than 1 reason could be listed as reason for revision. 
a This reason for revision might be a result of registration error.
For abbreviations, see Table 2.
